Skip to main content
SpringerLink
Log in

Prevention of cardiovascular disease: From biomedical research to health policy

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Cardiovascular diseases (CVD) are the leading cause of premature death and disability in the developed world. Broad consensus exists on CVD preventability through reduction of their risk factors at both the individual and population level. The latter kind of intervention implies involvement of policymaking institutions, owing to the manifold implications (agriculture, industry, environment) of such programmes. They have to be developed through three phases in succession: observational studies; intervention trials; public health action programmes. The implementation of the latter can only result from merging of biomedicine and politics and must rest on sound scientific-ethical bases. Other important issues are cost effectiveness, resort to mass media, transfer to other communities, funding and institutionalization. As a practical example of development and implementation of a public health programme, the experience of the ATS-Sardegna Campaign is briefly described.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

ATS:

Atherosclerosis

CHD:

Coronary heart disease

CNR:

(Italian) National Research Council

CVD:

Cardiovascular disease

GP:

General practitioner

References

  1. Rose G. The strategy of preventive medicine. Oxford: Oxford University Press, 1992.

    Google Scholar 

  2. Gross PF. Health care expenditures, ageing and medical technology: Towards a new paradigm for care and accommodation of aged and chronically-ill persons. In: The economics of health care: Challenges for the Nineties. London, UK: Mediq Ltd, 1990: 21–43.

    Google Scholar 

  3. Leaf A. Preventive medicine for our ailing health care system. JAMA 1993; 269: 616–618.

    Google Scholar 

  4. World Health Organization. Primary prevention of coronary heart disease. Euro Reports and Studies 98. Copenhagen: WHO, 1985.

    Google Scholar 

  5. Blackburn H. Development of public policy. In: Muntoni S, Epstein FH, Lamm G (eds), Epidemiology of atherosclerosis. Roma: CIC Edizioni Internazionali 1988: 97–104.

    Google Scholar 

  6. Epstein FH. What kinds of new intervention studies are still needed? In: Muntoni S, Epstein FH, Lamm G (eds), Epidemiology of atherosclerosis. Roma: CIC Edizioni Internazionali 1988: 105–110.

    Google Scholar 

  7. Hachinski V. Preventable senility: A call for action against the vascular dementias. Lancet 1992; 340: 645–648.

    Google Scholar 

  8. Salmon P, Brown M. Renal artery stenosis and peripheral vascular disease: Implications for ACE inhibition therapy. Lancet 1990; 336: 221.

    Google Scholar 

  9. Epstein FH. The progression of renal disease. New Engl J Med 1988; 318: 1657–1666.

    Google Scholar 

  10. Pole-Wilson PA, Sutton G. Coronary heart disease. Br Med J 1992; 304: 504–505.

    Google Scholar 

  11. Coughlin SS, Neaton JD, Sengupta A, Kuller LH. Predictors of mortality from idiopathic dilated cardiomiopathy in 356,222 men screened for the Multiple Risk Factor Intervention Trial. Am J Epidemiol 1994; 139: 166–172.

    Google Scholar 

  12. World Health Organization Expert Committee. Community prevention and control of cardiovascular disease. Technical Report Series 732. Copenhagen: WHO, 1986.

    Google Scholar 

  13. Rose G. Cardiovascular diseases. In: Holland WW, Detels R, Knox G (eds), Oxford textbook of public health, Vol 3. Oxford: Oxford University Press, 1991: 175–187.

    Google Scholar 

  14. World Health Organization Expert Committee. Prevention of coronary heart disease. Technical Report Series 678. Geneva: WHO, 1982.

    Google Scholar 

  15. Muntoni S. Rationale for prevention of cardiovascular disease in the community: The ATS-Sardegna model programme. In: Gotto Jr AM, Mancini M. Richter WO, Schwandt P (eds), Treatment of severe dyslipoproteinemia in the prevention of coronary heart disease 4. Basel: Karger, 1993: 7–15.

    Google Scholar 

  16. EEC Council. Directive No. 457, 15 September 1986.

  17. Leeder S, Gilksman M. Prospects for preventing heart disease. Br Med J 1990; 301: 1004–1005.

    Google Scholar 

  18. Rose G. Strategy of prevention: Lessons learned from cardiovascular disease. Br Med J 1981; 282: 1847–1851.

    Google Scholar 

  19. Puska P. The North Karelia Project: Nearly 20 years of successful prevention of CVD in Finland. Hygie 1992; 11: 33–35.

    Google Scholar 

  20. Feinleb M. The competing mortality effects of the decline in heart disease upon other causes of death. In: Lewis B, Assmann G (eds), The social and economic context of coronary prevention. London: Current Medical Literature Ltd, 1990: 11–21.

    Google Scholar 

  21. Menotti A. La prevenzione della cardiopatia coronarica, 2nd ed. Roma: Il Pensiero Scientifico Editore, 1989.

    Google Scholar 

  22. Epstein FH. Coronary heart disease prevention: Associated trends in chronic disease mortality. In: Lewis B, Assmann G (eds), The social and economic context of coronary prevention. London: Current Medical Literature Ltd, 1990: 32–36.

    Google Scholar 

  23. Puska P, Tuomilehto J, Nissinen A, et al. The North Karelia Project: 20 years' results and experiences. Hygie 1992; 11: 33.

    Google Scholar 

  24. Vartiainen E, Puska P, Pekkanen J, et al. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. Br Med J 1994; 309: 23–27.

    Google Scholar 

  25. Abelin T. Health promotion. In: Holland WW,Detels R, Knox G (eds), Oxford textbook of public health, Vol 3. Oxford: Oxford University Press, 1991: 557–589.

    Google Scholar 

  26. Fries JF, Green LW, Levine S. Health promotion and the compression of morbidity. Lancet 1989(i): 481–483.

  27. Beard TC. Greenhouse effect, renal calculi, and salt. Lancet 1990; 335: 412.

    Google Scholar 

  28. Stamler J, Rose G, Stamler R, et al. Intersalt study findings: Public health and medical care implications. Hypertension 1989; 14: 570–577.

    Google Scholar 

  29. Gruppo di Lavoro del GIEP e del CNR-ATS-OB43. Prevenzione della cardiopatia coronarica in Italia — Rapporto Rimini 84. G Arterioscl 1984; 9: 249–256.

    Google Scholar 

  30. Consensus Conference. Lowering cholesterol to prevent heart disease. JAMA 1985; 253: 2080–2086.

    Google Scholar 

  31. Consensus Conference Italiana. Abbassare la colesterolemia per ridurre la cardiopatia coronarica. G Arterioscl 1986; 11: 163–170.

    Google Scholar 

  32. Study Group, European Atherosclerosis Society. Strategies for prevention of coronary heart disease: A policy statement of the European Atherosclerosis Society. Eur Heart J 1987; 8: 77–88.

    Google Scholar 

  33. The Victoria Declaration on Heart Health. Health and Welfare Canada, Victoria, Canada, 28 May 1992.

  34. Ham C, Berman P. Health policy in Europe. Br Med J 1992; 304: 855–856.

    Google Scholar 

  35. Eddy DM. Three battles to watch in the 1990s. JAMA 1993; 270: 520–526.

    Google Scholar 

  36. Pinto FJ. New paradigms for health care. In: The economics of health care: Challenges for the Nineties. London: Mediq Ltd, 1990: 132–138.

    Google Scholar 

  37. Bos D, von Weizsacker RK. Economic consequences of an ageing population. Eur Economic Rev 1989; 33: 345–354.

    Google Scholar 

  38. Lamm RD. Columbus and Copernicus: New wine in old wineskins. The Mount Sinai J Med 1989; 56: 1–10.

    Google Scholar 

  39. Reckless JPD. The economics of cholesterol lowering. Balliere's Clinical Endocrinology and Metabolism 1990; 4: 947–972.

    Google Scholar 

  40. Leaf A. Management of hypercholesterolemia: Are preventive interventions advisable? New Engl J Med 1989; 321: 680–684.

    Google Scholar 

  41. Puska P, Tuomilehto J, Salonen J, et al. The North Karelia Project. Copenhagen: WHO, 1981.

    Google Scholar 

  42. Farquhar JW, Fortmann SP, Flora JA, et al. Effects of communitywide education on cardiovascular disease risk factors — The Stanford Five-City Project. JAMA 1990; 264: 359–365.

    Google Scholar 

  43. Kristiansen IS, Eggen AE, Thelle DS. Cost effectiveness of incremental programmes for lowering serum cholesterol concentration: Is individual intervention worthwhile? Br Med J 1991; 302: 1119–1122.

    Google Scholar 

  44. Fries JF, Koop E, Beadle CE, et al., and The Health Project Consortium. Reducing health care costs by reducing the need and demand for medical services. New Engl J Med 1993; 329: 321–325.

    Google Scholar 

  45. Ottawa Charter for Health Promotion. Health Promotion 1986; 1 (4): iii–iv.

  46. World Health Organization. Proceedings of an international conference on primary care — Declaration of Alma-Ata. Geneva: WHO, 1978.

    Google Scholar 

  47. Fitzgerald FT. The tyranny of health. New Engl J Med 1994; 331: 196–198.

    Google Scholar 

  48. MacFarlane A. Health promotion and children and teenagers: Why it is mainly the government's responsibility. Br Med J 1993; 306: 81.

    Google Scholar 

  49. Farquhar JW, Fortmann SP, Flora JA, Maccoby N. Methods of communication to influence behaviour. In: Holland WW, Detels R, Knox G (eds), Oxford textbook of public health, Vol 2. Oxford: Oxford University Press, 1991: 331–344.

    Google Scholar 

  50. Longfield J, Rayner M. Preventing cardiovascular disease in Europe. London: HMSO, 1993.

    Google Scholar 

  51. Muntoni S. The ATS-Sardegna Campaign for cardiovascular disease prevention and health promotion. Eur J Epidemiol 1992; 8: 108–111.

    Google Scholar 

  52. Feruglio GA. The regional project for the prevention of cardiovascular disease and health promotion of Friuli-Venezia Giulia. CVD Newsletter 1994; 49: 125–126.

    Google Scholar 

  53. New York State Healthy Heart Programme. Heart Memo. NHLBI, Spring 1994: 26–27.

  54. HBP Prevention Campaign of the NHBPEP. Heart Memo. NHLBI, Spring 1994: 3.

  55. National Cholesterol Education Programme. Heart Memo. NHLBI, Spring 1994: 12–13.

  56. Goodman DWS. Strategies and programmes for prevention in the 1990s. In: Stein O, Eisenberg S, Stein Y (eds), Atherosclerosis IX. Tel Aviv: R&L Creative Communications Ltd, 1992: 377–382.

    Google Scholar 

  57. Stern MP. Primary prevention of type II diabetes mellitus. Diabetes Care 1991; 14: 399–410.

    Google Scholar 

  58. Varttiainen E, Tossavainen K, Viri L, Niskanen E, Puska P. The North Karelia Youth Programmes. In: Williams CL, Wynder EL (eds), Hyperlipidemia in childhood and the development of atherosclerosis. Ann NY Acad Sci 1991; 623: 332–339.

    Google Scholar 

  59. Dan BB. TV or not TV: Communicating health information to the public. JAMA 1994; 268: 1026–1027.

    Google Scholar 

  60. Jeffres LW. Mass media: Processes and effects. Prospect Heights, IL: Waveland Press, 1986: 119–163.

    Google Scholar 

  61. Encyclopaedia Britannica, Book of the Year. Chicago, 1994.

  62. Cavalli-Sforza LL, Piazza A. Human genomic diversity in Europe: A summary of recent research and prospects for the future. Eur J Hum Genet 1993; 1: 3–18.

    Google Scholar 

  63. Luzzatto L, Usanga EA, Reddy S. Glucose-6-phosphate dehydrogenase deficient red cells: Resistance to infection by malarial parasites. Science 1969; 164: 839–842.

    Google Scholar 

  64. Annuario Statistico Italiano. Rome: ISTAT, 1987.

  65. Muntoni S, Batetta B, Dessi S, Muntoni Sa, Pani P. Serum lipoprotein profile in the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency. Eur J Epidemiol 1992; 8 (suppl 1): 48–53.

    Google Scholar 

  66. Crowley JP, Sheth S, Capone RJ, Schilling RF. A paucity of thalassemia trait in Italian men with myocardial infarction. Acta Haemat 1987; 78: 249–251.

    Google Scholar 

  67. The Research Group of the Italian National Research Council. Distribution of some risk factors for atherosclerosis in nine Italian population samples. Am J Epidemiol 1981; 113: 338–346.

    Google Scholar 

  68. Gruppo di Ricerca ATS-OB43. I fattori di rischio cardiovascolare in Italia: Aggiornamento agli anni 1980 dello studio delle nove communità. Card Prev Riab 1987; 5: 75–137.

    Google Scholar 

  69. Muntoni S, Pintus F, Mascia P, et al. Mean levels and distribution of some risk factors for atherosclerosis in Sardinia: The ATS-Sardegna Survey. Eur J Epidemiol 1991; 7: 39–47.

    Google Scholar 

  70. The Research Group for Atherosclerosis Risk factors (ATS-RF2), Rome, Italy. Three year intervention on risk factors for atherosclerosis in the Italian Nine Communities Study. Clin Terap Cardiovasc 1986; 3: 151–158.

    Google Scholar 

  71. Muntoni S, on behalf of the ATS-Sardegna Research Group. Parallel increase in saturated fat intake and mean plasma cholesterol levels in Sardinia, during a six-year period. Washington: Xth World Congress of Cardiology, Abstr. 2593, 1986.

  72. La prevenzione delle malattie cardiovascolari: il modello CNR — Regione Sardegna. In: Fatma News. Rome: CNR, 1993, 9 pp.

  73. Muntoni S. Collaboration between CNR and Regione Sardegna: The ATS-Sardegna campaign. Eur J Epidemiol 1994; 10/3 (suppl 1): S2-S3.

    Google Scholar 

  74. Welch HG, Larson EB. Dealing with limited resources: The Oregon decision to curtail funding for organ transplantation. New Engl J Med 1988; 319: 171–173.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Metabolic Diseases and Atherosclerosis, the ME.DI.CO. Association, Cagliari, Italy

    Sergio Muntoni

Authors
  1. Sergio Muntoni
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muntoni, S. Prevention of cardiovascular disease: From biomedical research to health policy. Eur J Epidemiol 11, 485–494 (1995). https://doi.org/10.1007/BF01719298

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01719298

Key words

Search

Navigation